Community Collaboratives Sample Clauses

The 'Community Collaboratives' clause establishes the framework for joint efforts or partnerships among various community stakeholders, such as organizations, agencies, or individuals, to achieve shared goals. This clause typically outlines how members are selected, the scope of collaborative activities, decision-making processes, and the sharing of resources or information. Its core practical function is to formalize cooperation, ensuring that all parties understand their roles and responsibilities, thereby promoting effective collaboration and reducing misunderstandings.
Community Collaboratives. Community Health Team (CHT) Staffing and Design A.5. Extended and Functional CHT Integration A.6. Practice Outreach and Communication A.7. Unified Performance Reporting and Data Utility A.8. Payment Processes A.9. Program Evaluation Participation
View SourceView Similar (7)
Community Collaboratives. Local implementation of the State’s Blueprint for Health requires the participation of a wide array of community partners and stakeholders to:  Operate community health team(s) (CHTs)  Coordinate health information technology (HIT) connectivity  Support the development of a learning health systemParticipate in regional ACO planning and other health reform activities The Contractor shall work directly with ACO(s) within the HSA to facilitate the formation and maintenance of a Community Collaborative (CC) to align quality improvement initiatives and care coordination activities, to strengthen Vermont’s community health infrastructure, and to help the ACO provider networks within each community meet their organizational goals. The CCs shall promote the cohesive integration of health and human services addressing both the medical and non-medical needs that impact measurement results and outcomes, including social, economic, and behavioral factors. The CC structure, with administrative support locally from the Blueprint and the ACOs, will result in more effective health services as measured by:  Improved results for priority measures of quality  Improved results for priority measures of health status  Improved patterns of services utilization (preventive services, unnecessary care)  Improved access and patient experience of care The CC structure includes three (3) basic elements: (1) Leadership Team (Governance)
View SourceView Similar (7)
Community Collaboratives. Local and regional convenings of county agencies, community-based organizations, nonprofits, Members, relatives/ natural supports, health care Providers, and peers that meet regularly to identify and address community needs through coordinated efforts and system planning. Community Integration Plan (CIP): A planning document completed as part of the diversion process that documents that community integration planning occurred and indicates which residential option and other services were chosen by the Member and/or their relatives or guardian. Compatible Medicaid NCCI Methodologies: The six (6) NCCI Methodologies used in the Medicare Part B program and determined by CMS as compatible methodologies for claims filed in Medicaid: (1) a methodology with procedure-to procedure edits for practitioner and ambulatory surgical center services; (2) a methodology with procedure-to-procedure edits for outpatient services in hospitals (including emergency department, observation, and hospital laboratory services); (3) a methodology with procedure-to-procedure edits for durable medical equipment; (4) a methodology with medically unlikely edits for practitioner and ambulatory surgical center services; (5) a methodology with medically unlikely edits for outpatient services in hospitals; and (6) a methodology with medically unlikely edits for durable medical equipment. Although the Medicare methodologies are compatible for Medicaid, the actual edits used are not identical between programs. Conflict of Interest: Impermissible actual situations or circumstances through which the PIHP, or entities or individuals closely affiliated with the PIHP, will derive, or reasonably may be perceived as deriving, direct financial or other pecuniary benefit from its performance of this Contract other than through the compensation received according to the Contract for performance of the Contract, or that might impair, or reasonably be perceived as impairing, the PIHP’s ability to perform this Contract in the best interests of the State.
View Source
Community Collaboratives. Local implementation of the State’s Blueprint for Health requires the participation of a wide array of community partners and stakeholders to:  Operate community health team(s) (CHTs)  Coordinate health information technology (HIT) connectivity  Support the development of a learning health systemParticipate in regional ACO planning and other health reform activities The Contractor shall work directly with ACO(s) within the HSA to facilitate the formation and maintenance of a Community Collaborative (CC) (may be called by a different name in the local health service area) to align quality improvement initiatives and care coordination activities, to strengthen Vermont’s community health infrastructure, and to help the ACO provider networks within each community meet their organizational goals. The CCs shall promote the cohesive integration of health and human services addressing both the medical and non-medical needs that impact measurement results and outcomes, including social, economic, and behavioral factors. The CC structure, with administrative support locally from the Blueprint and the ACOs, will result in more effective health services as measured by:  Improved results for priority measures of quality  Improved results for priority measures of health status  Improved patterns of services utilization (preventive services, unnecessary care)  Improved access and patient experience of care The CC structure includes three (3) basic elements: (1) Leadership Team (Governance)
View Source
Community Collaboratives. Community Health Team (CHT) Staffing and Design
View Source

Related to Community Collaboratives

  • Research Collaboration Upon FibroGen’s request, the Parties will discuss conducting a research program funded by AstraZeneca and directed toward franchise enhancement and lifecycle management for HIF Compounds or other topics that the Parties determine relevant to the Products and the Field. Upon agreement on the terms of such research program, the Parties will enter into a separate agreement or amend this Agreement accordingly.

  • Collaboration activities 4.1 The Collaboration Suppliers will perform the Collaboration Activities and all other obligations of this Agreement in accordance with the Detailed Collaboration Plan. 4.2 The Collaboration Suppliers will provide all additional cooperation and assistance as is reasonably required by the Buyer to ensure the continuous delivery of the services under the Call-Off Contract. 4.3 The Collaboration Suppliers will ensure that their respective subcontractors provide all cooperation and assistance as set out in the Detailed Collaboration Plan.

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

  • Research Primary Investigator as part of a multi-site study (25 points) • Co-Investigator as part of a multi-site study (20 points) • Primary Investigator of a facility/unit based research study (15 points) • Co-Investigator of a facility/unit based research study (10 points) • Develops a unit specific research proposal (5 points) • Conducts a literature review as part of a research study (5 points)

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).